Research is exploring the role of the microbiome in cancer treatment, particularly in melanoma immuno-oncology. Studies are investigating how the gut microbiome and microbiota-derived metabolites may influence cancer immunotherapy response and contribute to immunoresistance. The intersection of microbiome research and cancer treatment is an area of ongoing investigation, with various symposia and awards recognizing advances in this field.